First Japanese case of carnitine palmitoyltransferase II deficiency with the homozygous point mutation S113L

9Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Carnitine palmitoyltransferase II (CPT II) deficiency is a rare inherited disorder related to recurrent episodes of rhabdomyolysis. The adult myopathic form of CPT II deficiency is relatively benign and difficult to diagnose. The point mutation S113L in CPT2 is very common in Caucasian patients, whereas F383Y is the most common mutation among Japanese patients. We herein present a case of CPT II deficiency in a Japanese patient homozygous for the missense mutation S113L. The patient showed a decreased frequency of rhabdomyolysis recurrence after the administration of a diet containing medium-chain triglyceride oil and supplementation with carnitine and bezafibrate.

Cite

CITATION STYLE

APA

Shima, A., Yasuno, T., Yamada, K., Yamaguchi, M., Kohno, R., Yamaguchi, S., … Fukuda, H. (2016). First Japanese case of carnitine palmitoyltransferase II deficiency with the homozygous point mutation S113L. Internal Medicine, 55(18), 2659–2661. https://doi.org/10.2169/internalmedicine.55.6288

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free